Iambic Therapeutics, Inc. IAM

IPO NASDAQ
IPO Score
IPO Date
Oct 14, 2026
Recommendation
Dividend Power Score
Day's Range
$13.60$16.50
Latest Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)

06/30/2026
Net Income 0.00%
Total Depreciation and Amortization 0.00%
Total Amortization of Deferred Charges --
Total Other Non-Cash Items 0.00%
Change in Net Operating Assets 0.00%
Cash from Operations 0.00%
Capital Expenditure 0.00%
Sale of Property, Plant, and Equipment --
Cash Acquisitions --
Divestitures --
Other Investing Activities --
Cash from Investing 0.00%
Total Debt Issued --
Total Debt Repaid 0.00%
Issuance of Common Stock 0.00%
Repurchase of Common Stock --
Issuance of Preferred Stock 0.00%
Repurchase of Preferred Stock --
Total Dividends Paid --
Other Financing Activities --
Cash from Financing 0.00%
Foreign Exchange rate Adjustments 0.00%
Miscellaneous Cash Flow Adjustments --
Net Change in Cash 0.00%